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Abstract
In previous studies on the mechanism underlying megakaryocyte-specific gene expression, several ETS motifs were found in
each megakaryocyte-specific gene promoter. Although these studies suggested that several ETS family proteins regulate
megakaryocyte-specific gene expression, only a few ETS family proteins have been identified. Platelet factor 4 (PF4)i sa
megakaryocyte-specific gene and its promoter includes multiple ETS motifs. We had previously shown that ETS-1 binds to
an ETS motif in the PF4 promoter. However, the functions of the other ETS motifs are still unclear. The goal of this study was
to investigate a novel functional ETS motif in the PF4 promoter and identify proteins binding to the motif. In electrophoretic
mobility shift assays and a chromatin immunoprecipitation assay, FLI-1, ELF-1, and GABP bound to the 251 ETS site.
Expression of FLI-1, ELF-1, and GABP activated the PF4 promoter in HepG2 cells. Mutation of a 251 ETS site attenuated FLI-
1-, ELF-1-, and GABP-mediated transactivation of the promoter. siRNA analysis demonstrated that FLI-1, ELF-1, and GABP
regulate PF4 gene expression in HEL cells. Among these three proteins, only FLI-1 synergistically activated the promoter
with GATA-1. In addition, only FLI-1 expression was increased during megakaryocytic differentiation. Finally, the importance
of the 251 ETS site for the activation of the PF4 promoter during physiological megakaryocytic differentiation was
confirmed by a novel reporter gene assay using in vitro ES cell differentiation system. Together, these data suggest that FLI-
1, ELF-1, and GABP regulate PF4 gene expression through the 251 ETS site in megakaryocytes and implicate the
differentiation stage-specific regulation of PF4 gene expression by multiple ETS factors.
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Introduction
Megakaryocytic differentiation is accompanied by drastic
morphological changes that are induced by endomitosis and
proplatelet formation. To understand the molecular mechanism of
megakaryocyte-specific gene regulation during this unique differ-
entiation process, several megakaryocyte-specific gene promoters,
including the promoters of platelet factor 4 (PF4), c-Mpl,
Glycoprotein (GP) IIb, GPV, GPIX, GPVI, GPIb and platelet
basic protein (PBP), have been studied (reviewed in [1]). Each of
these promoters includes multiple GATA and ETS motifs.
GATA-1 is shown to bind to the GATA motifs in most
megakaryocyte-specific gene promoters. GATA-1 is one of the
zinc finger transcription factors; it recognizes the T/AGATAA/G
motif and promotes megakaryocytic and erythroid development.
GATA-1 binds to GATA motifs in the megakaryocytic gene
promoters and activates the gene expression (reviewed in [1]). On
the other hand, multiple ETS family transcription factors, such as
FLI-1 and PU.1, are known to bind to ETS motifs in each
megakaryocyte-specific gene promoter. The members of the ETS
family of transcription factors share an evolutionarily conserved
DNA-binding domain of 85 amino acids with a winged-helix-turn-
helix configuration [2]. ETS factors bind to GGAA/T core
sequences. FLI-1 is known to be a positive regulator of
megakaryocyte-specific gene expression. FLI-1 regulates several
megakaryocyte-specific genes, including GPIIb, GPVI, GPIX and
c-Mpl. FLI-1 interacts with GATA-1 and enhances its binding to
DNA [3]. Homozygous FLI-1 knockout is embryonic lethal in
mice and shows severe dysmegakaryopoiesis. PU.1 is known to be
a transcriptional activator of the GPIIb and PBP genes [4,5].
However, PU.1 is also reported to interact with GATA-1 and
inhibit GATA-1 function through several possible mechanisms
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24837[6,7,8,9,10,11]. This indicates that PU.1 may function as a
negative regulator of megakaryocyte-specific gene expression.
To investigate the mechanism underlying megakaryocyte-
specific gene expression, we have been studying the regulatory
mechanism of the PF4 gene expression by using the rat PF4
promoter. We demonstrated that several transcription factors (e.g.
GATA-1, ETS-1, MEIS1, PBX1/2, PREP1 and USF1/2) bind to
the proximal promoter region and activate the PF4 gene
expression [12,13,14,15]. ETS-1 has been shown to activate the
PF4 promoter through the 273 ETS site. However, the functions
of several other ETS motifs in the PF4 promoter are still unknown.
In the present study, we identified the 251 ETS site as a novel
functional site in the promoter. The importance of the 251 ETS
site for the activation of PF4 gene expression in physiological
megakaryocytic differentiation was demonstrated by a novel ES
cell differentiation system. Based on EMSA and coexpression
assays, 3 ETS family proteins, FLI-1, ELF-1, and GABP were
shown to bind to the 251 ETS site and regulate the PF4
promoter. Analysis of expression patterns of FLI-1, ELF-1, and
GABP during megakaryocytic differentiation suggested the differ-
entiation stage-specific function of ETS factors. Thus, we
succeeded in identifying multiple ETS family proteins that regulate
megakaryocyte-specific PF4 gene expression through the novel
ETS site.
Materials and Methods
Preparation of plasmids and targeting vectors
The Rat PF4 promoter (PF4-luc) and human PF4 (hPF4-luc)
reporter constructs were previously described [12,14]. To generate
the PF4 promoter deletion constructs (Del-500, Del-300, and Del-
100), rat PF4 promoter upstream fragments were amplified by
polymerase chain reaction (PCR) using 3 different primer sets
(DNA sequences are shown in Table S1). The resulting fragments
were phosphorylated by T4 DNA kinase and cloned into the SmaI
site of PGV-B (TOYO B-Net, Tokyo, Japan). All DNA sequences
were verified by automated DNA sequencing.
To generate the two PF4 promoter mutants containing a single
mutation in 273 or 251 ETS site (273 ETSmut and 251
ETSmut), an intermediate plasmid containing mutations in both
sites (273/251 ETSmut) was prepared by two-step PCR
amplification. In the first step, the rat PF4 promoter fragment
was amplified by PCR using PF4-luc as a template and primers for
the first PCR. In the second step, PCR was performed using
primers (the first PCR product and a new primer) and PF4-luc as a
template. The resulting 0.2-kb promoter fragment containing the
273 and 251 ETS mutations was digested with KpnI and ligated
with the 6.4-kb fragment of PvuII-KpnI digested PF4-luc. To
generate the 251 ETSmut, 273/251 ETSmut was digested with
SmaI and the 0.7-kb fragment containing the 251 ETS mutation
was ligated with the 5.9-kb fragment of SmaI-digested PF4-luc. To
generate the 273 ETSmut, PF4-luc was digested with SmaI and
the 0.7-kb fragment was ligated with the 5.9-kb fragment of SmaI-
digested 273/251 ETSmut. The DNA sequences of all the
constructs were verified by automated DNA sequencing. All the
primer sequences are shown in Table S1.
To generate FLI-1, PU.1, and GATA-1 expression vectors,
cDNAs for FLI-1, PU.1, and GATA-1 were PCR amplified using
HEL cDNA and gene-specific primers (shown in Table S1). The
resulting PCR fragments were phosphorylated with T4 DNA
kinase and cloned into the EcoRV site of pcDNA3 (Invitrogen,
Carlsbad, CA). DNA sequences were verified by automated DNA
sequencing. To generate the ELF-1 expression vector (pcDNA3-
ELF-1), pCI-ELF-1 (a generous gift from Peter Oettgen) was
digested with KpnI and XbaI, and the resulting ELF-1 fragment was
cloned into pcDNA3. Preparation of ETS-1 and GABP expression
vectors was described previously [12,16].
To generate the Hprt-targeting vector with the rat PF4
promoter (pMP8II-PF4-AcGFP), a 1.1-kb region of the PF4
promoter was amplified by PCR using PF4-luc as a template. The
resulting promoter fragment was digested with XhoI and SacII, and
cloned into the XhoI-SacII site of pAcGFP1-1 (Takara, Siga, Japan)
to generate PF4-AcGFP. The promoter sequence was verified by
automated DNA sequencing. PF4-AcGFP was then digested with
AflII and blunt-ended with T4 DNA polymerase. The resulting
DNA was digested with MluI. A 2.1-kb fragment containing PF4
promoter coupled to GFP was purified and cloned between the
MluI and PmeI sites of pMP8II [17]. To generate the targeting
vector with a mutation of the 251 ETS site (pMP8II-PF4 (251
ETSmut)-AcGFP), a 170 bp fragments spanning the mutation was
PCR amplified using the 251 ETSmut plasmid as a template. The
resulting promoter fragment was digested with ScaI and SacII, and
cloned between the ScaI and SacII sites of PF4-AcGFP. The
promoter sequence in the obtained plasmid (PF4(251ETSmut)-
AcGFP) was verified by automated DNA sequencing.
PF4(251ETSmut)-AcGFP was then digested with AflII and
blunt-ended with T4 DNA polymerase. The resulting DNA was
digested with MluI and 2.1-kb fragment was cloned between the
MluI and PmeI sites of pMP8II.
Cell culture and transient transfection assays
HEL cells were maintained in RPMI 1640 medium supple-
mented with 10% fetal bovine serum, 100 IU/ml penicillin and
100 mg/ml streptomycin. HepG2 cells were maintained under the
same conditions except that Dulbecco’s modified Eagle’s medium
(DMEM) was used. In transient transfection assays with HepG2
cells, 0.5 mg of PF4-luc or hPF4-luc were transfected into 2610
5
cells with or without 0.5 mg of each expression vector, using the
Lipofectamine 2000 reagent (GIBCO BRL, Gaithersburg, MD).
To control for transfection efficiency, the cells were also
transfected with 0.5 mgo fp bactin-lacZ. In the assay with HEL
cells, 7 mg each of the reporter plasmids and pbactin-lacZ were
transfected into 1610
7 cells by electroporation as described
previously [18]. Transfected cells were cultured for 48 hr and
assayed for luciferase and b-galactosidase activity. Each assay was
performed in duplicate more than three times.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from HEL cells using Nuclear
Extract Kit (Active Motif, Carlsbad, CA). In vitro translated ETS-
1, PU.1, FLI-1, ELF-1, and GABP were prepared using the TNT
Quick Coupled transcription/translation System (Promega, Ma-
dison, WI) and 1 mg of expression vectors. To generate EMSA
probes, oligonucleotides were annealed, labeled with T4 polynu-
cleotide kinase and [c-P
32] ATP, and purified with G-50 micro
columns (Amersham Pharmacia Biotech, Uppsala, Sweden).
Binding reactions were carried out using 50 fmol of each probe,
3t o5mg nuclear extract or 2 to 4 ml of in vitro translated proteins
in binding buffer (2 mM HEPES-NaOH (pH 7.9), 2% glycerol,
0.01 mM EDTA, 0.25 mM DTT, 5 mM KCl, 0.1 mg/ml bovine
serum albumin, 5 ng/ml poly dI-dC) for 40 min at 4uC. For
competition and supershift assays, competitor oligonucleotides or
antibodies were pre-incubated with nuclear extract or in vitro
translated proteins for 10 min prior to addition of the probe.
Antibodies to ETS-1 (C-20), PU.1 (T-21), FLI-1 (C-19), ELF-1 (C-
20), GABPa (H-180), GABPb1/2 (H-265), and Stat5 (C-17) used
as a control antibody were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Gel electrophoresis was carried
ETS Family Proteins Regulating PF4 Gene Expression
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120 V. All the oligonucleotides sequences are shown in Table S1.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using a ChIP-IT Express kit
(Active Motif, Carlsbad, CA). Briefly, crosslinked genomic DNA
was prepared from HEL cells and sheared by sonication using the
Digital sonifer model 250 (Branson, Danbury, CT). Resulting
DNA-protein complexes were immunoprecipitated using 3 mgo f
antibodies against FLI-1, ELF-1, GABPa, or control IgG. The
precipitated DNA fragments were analyzed by real-time PCR
using primers (sequences are shown in Table S1) to amplify the
promoter region including the 251 ETS sites or GAPDH locus as
a control.
siRNA -mediated knockdown of FLI-1, ELF-1, and GABPa
HEL cells (1610
7 cells) were electroporated with 150 to
300 pmol of siRNAs for FLI-1, ELF-1, GABPa or control
(sequences are shown in Table S1) as described previously [19].
Cells were incubated for 2 days and then processed for total RNA
isolation using RNeasy plus mini kit (Qiagen, Germantown, MD).
Each cDNA was synthesized from 0.5 mg of total RNA using
SuperscriptIII first-strand synthesis system (Invitrogen) and used
for real-time RT-PCR analyses. Expression levels of PF4, FLI-1,
ELF-1, and GABPa were normalized by a GAPDH expression level.
siRNA target and primer sequences are shown in Table S1.
RT-PCR using cDNA from human megakaryocytes or cell
lines
Buffy coat peripheral blood (PB) cells were obtained from
volunteer blood donors. PB was collected after written consent that
was obtained from the volunteer blood donors. All the protocols
were approved by the ethic committees in Japanese Red Cross
Osaka Blood Center and Osaka University. AC133
+ cells were
isolated from PB mononuclear cells by a MACS AC133 Cell
Isolation Kit (Miltenyi Biotech, Auburn, CA), as described
previously [20]. Purified AC133
+ cells were cultured in IMDM
containing 20% human serum, 50 IU/ml penicillin, 50 mg/ml
streptomycin, and 10 ng/ml thrombopoietin (TPO) (PeproTech
Inc., Rocky Hill, NJ). The same amount of TPO was added to the
medium every two days, and half of the medium was replaced with
new medium after 6 days of incubation. Cells were incubated for
0, 4, 6, or 10 days and then processed for total RNA using
ISOGEN (Nippon gene, Tokyo, Japan). Each cDNA was
synthesized from 0.5 to 1 mg of total RNA using ReveTra Ace
(Toyobo, Osaka, Japan) and used for real-time RT-PCR analyses.
The same procedure was used for the preparation of cDNA from
HepG2 and HEL cells. All the primer sequences are shown in
Table S1.
Generation and differentiation of HPRT-targeted ES cells
Undifferentiated Hprt-deficient BK4 ES cells (a generous gift
from Sarah Bronson) were maintained and propagated on mouse
embryonic fibroblast cells in Knockout DMEM (Invitrogen)
supplemented with 15% FBS, 1% Glutamax-I (Invitrogen),
100 IU/ml penicillin, 100 mg/ml streptomycin, 0.1 mM MEM
non-essential amino acids (Invitrogen), 0.1 mM 2-mercaptoetha-
nol, and 1000 U/ml ESGRO (LIF) (Millipore, Billerica, MA). To
generate homologous recombinants, ES cells were electroporated
with 25 mgo fSalI-linearized targeting vectors (pMP8II-PF4-
AcGFP and pMP8II-PF4(251 ETSmut)-AcGFP). Homologous
recombinants were selected in the medium containing HAT
(SIGMA, St. Louis, MO) for approximately 10 days, at which time
individual colonies were picked for expansion and verification of
the desired recombination. At least 2 independent ES cell lines
were established for each construct. Established ES cell lines were
differentiated into megakaryocytes on OP9 stroma cells by
culturing for 8 to 10 days in the medium containing 10 ng/ml
TPO according to the method as described previously [21].
Flow cytometry
Two ES cell lines containing the PF4 promoter, with or without
a mutation in the 251 ETS site, and a non-recombined control ES
cell line were differentiated into megakaryocytic cells for 8 days.
The resulting cells were treated with 0.25% Trypsine and
collected. The cells (4610
5 cells) were then incubated with
phycoerythrin-conjugated rat anti-mouse CD41 antibody (BD
pharmingen, Franklin Lakes, NJ) or phycoerythrin-conjugated
control rat IgG (BD pharmingen) in phosphate-buffered saline
containing 0.5% BSA at 4uC for 30 min. The cells were washed 3
times and analyzed by a flow cytometer.
DNA sequences for the PF4 promoter
The DNA sequences of the rat, mouse, and human PF4
promoters are obtained from Genbank. Accession numbers are
M83070.1, NW_001030791.1, and NT_022778.16 for the rat,
mouse, and human promoters, respectively.
Statistical analyses
The statistical significance of differences of the means was
determined by Student t test.
Results
PF4 promoter activity is mediated by the ETS
transcription factors ETS-1, PU.1, and FLI-1
We have previously shown that ETS-1 mediates expression of
PF4 [12]. Other ETS factors, including PU.1 and FLI-1, have
been implicated in megakaryocyte-specific gene expression [3,4].
To determine the temporal expression of these genes, we
employed a human megakaryocyte differentiation assay. Hema-
topoietic progenitor (AC133
+) cells from human peripheral blood
cells were differentiated into megakaryocytes by adding thrombo-
poietin (TPO). The cells were processed 0, 4, 6, and 10 days later
for RNA isolation and assayed by real-time PCR for expression of
PF4 and the relevant transcription factors (Figure 1). PF4
demonstrated a time-dependent increase in expression, indicating
that AC133
+ cells were differentiating into the megakaryocytic
lineage. A similar pattern was observed for NF-E2p45,a
transcription factor that has been shown to play an important
role during the late stages of megakaryocytic differentiation
(reviewed in [22]). The expressions of ETS-1, PU.1, and FLI-1
preceded that of PF4. Detectable expression of the megakaryocytic
transcription factor, GATA-1, coincided with that of PF4. These
results are consistent with a role for FLI-1 and PU.1 in regulating
PF4 gene expression.
To determine whether PU.1 or FLI-1 mediate PF4 promoter
activity, we employed co-expression assays using HepG2 cells. We
chose these cells because it lacks detectable expression of ETS-1,
PU.1, FLI-1, and GATA-1 (Figure 2A). Overexpression of ETS-1
or PU.1 resulted in a small induction of the rat PF4 promoter
activity, while FLI-1 strongly activated the PF4 promoter
(Figure 2B). Overexpression of GATA-1 with FLI-1 but not
with ETS-1 or PU.1 resulted in synergistic activation of the PF4
promoter (Figure 2B; Figure S1). A similar pattern was
observed with the human PF4 promoter (Figure 2C). These
ETS Family Proteins Regulating PF4 Gene Expression
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expression.
FLI-1 activates the PF4 promoter activity through the
251 ETS site
In order to identify the FLI-1 binding site that regulates PF4
promoter activity, we cotransfected HepG2 cells with progressively
shortened 59-deletion fragments of the PF4 promoter. As shown in
Figure 3A, deletion constructs containing 500, 300, and 100 bp
of the upstream promoter region (Del-500, Del-300, and Del-100,
respectively) were all activated by FLI-1. These findings suggest
that the FLI-1-responsive DNA element is contained within
100 bp of the transcriptional start site. A comparative analysis of
this region revealed 2 highly conserved ETS consensus elements at
Figure 1. Expression of PF4 and transcription factors during megakaryocytic differentiation. The hematopoietic progenitor (AC133
+)
cells from human peripheral blood were cultured with TPO and differentiated into megakaryocytes. After culturing the cells for 0, 4, 6, and 10 days,
the expression of PF4, the transcription factors, and GAPDH (as an internal control) were analyzed by real-time RT-PCR. Data are represented as the
mean 6 SE.
doi:10.1371/journal.pone.0024837.g001
Figure 2. FLI-1 and GATA-1 synergistically activate the PF4 promoter. (A) Expression of ETS family proteins and GATA-1 in megakaryocytic
HEL cells and non-megakaryocytic HepG2 cells. (B, C) Coexpression assays were performed in HepG2 cells with expression vectors for ETS-1, PU.1, FLI-
1, and GATA-1 and with luciferase constructs including the rat (B) or human (C) PF4 promoter. All the coexpression assays were performed 3 times.
Data are represented as the mean 6 SE. * p,0.05 between Control and each expression vector.
doi:10.1371/journal.pone.0024837.g002
ETS Family Proteins Regulating PF4 Gene Expression
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were responsible for mediating the positive effect of FLI-1 on PF4
promoter activity, we co-transfected HepG2 cells with a FLI-1
expression vector and a wild type or a mutant PF4 promoter-
reporter plasmid containing a mutation in the 273 or 251 ETS
sites (273 ETSmut and 251 ETSmut, respectively). Mutation of
the 251 ETS site resulted in a significant reduction in FLI-1-
mediated promoter activation, while mutation of the 273 ETS
had little effect (Figure 3C). Consistent with this result, the
mutation of the 251 ETS site also resulted in a significant
reduction in synergistic promoter activation mediated by FLI-1
and GATA-1, while the mutation of the 273 ETS had no effect
(Figure 3C). A similar result was obtained with an assay using
Del-100, with or without a mutation in the 273 or 251 ETS site
(Figure S2). These results indicated that the 251 ETS site is a
FLI-1 responsive element and important for synergistic promoter
activation by FLI-1 and GATA-1. A mutation of the 251 ETS site
resulted in a significant decrease of the promoter activity in the
PF4-expressing megakaryocytic HEL cell (Figure 3D). To
determine whether FLI-1 plays a role in mediating the expression
of the endogenous PF4 gene, siRNA against FLI-1 was transfected
into HEL cells. FLI-1 siRNA resulted in 67% and 56% reduction
of FLI-1 and PF4 mRNA expression, respectively (Figure 3E).
Together, these data suggest that FLI-1 regulates PF4 gene
expression through the 251 ETS site.
ETS transcription factors bind to the 251 ETS site
To determine which ETS factors bind to the 251 ETS site in
megakaryocytic cells, electrophoretic mobility shift assay (EMSA)
was performed using a probe spanning the 251 ETS site and
nuclear extract from HEL cells. Four shifted bands were observed
(Figure 4A; Band I, II, IIIa, and IIIb, respectively). Band IIIa and
IIIb were detected almost at the same position. Band I, II, and IIIa
were inhibited by the addition of a cold wild type competitor
probe, but not a mutant competitor probe (Figure 4A; lanes 3–6).
Band IIIb was inhibited by the addition of both wild type and
mutant competitor probes, suggesting that band IIIb is not derived
from a protein which specifically binds to the 251 ETS site.
Incubation of the reaction mixture with anti-FLI-1 antibody, but
not control antibody resulted in a supershifted band (Figure 4A;
lanes 7 and 8). Consistent with these results, EMSA using in vitro
translated FLI-1 indicated that FLI-1 binds to the 251 ETS site
and that a FLI-1-DNA complex is observed to have a size similar
to that of band IIIa (Figure 4B).
The above results suggested that ETS factors other than FLI-1
were involved in the DNA-protein complexes corresponding to
band I and II. To identify these factors, we performed supershift
assays with antibodies against other ETS proteins. Band I was
inhibited by addition of anti-ELF-1 antibody, while band II was
inhibited by anti-GABP antibody (Figure 4C; lanes 3–5). Control
IgG had no effect on the DNA-protein complexes (Figure 4C;
lane 7). EMSA was performed with in vitro translated ELF-1 and
GABP. GABP binds as a complex consisting of heterodimers of
GABPa and GABPb or c (reviewed in [23]). The recombinant
ELF-1 resulted in a DNA-protein complex that migrated at the
same position as band I (Figure 4D; lane 4). Anti-ELF-1 antibody
inhibited the complex and resulted in a weak super-shift band
(Figure 4D; lane 5). The recombinant GABPa together with
GABPb and/or GABPc resulted in DNA-protein complexes that
corresponded in size to band II (Figure 4E). FLI-1, ELF-1, and
GABP (containing recombinant GABPa, GABPb and GABPc) did
not bind to a probe containing a mutation of the 251 ETS site,
Figure 3. FLI-1 activates the PF4 promoter through the 251 ETS site. (A) Schematic representation of the rat PF4 promoter-reporter
constructs including the 1.1-kb promoter (wild type) and the deleted promoters (Del-500, Del-300, and Del-100). ETS consensus motifs, including the
GGAA core sequence are indicated by closed boxes. The coexpression assay was performed by transfecting these constructs and a FLI-1 expression
vector into HepG2 cells. (B) Two conserved ETS motifs and a functional GATA motif (reported in [12]) in the 100-bp 59-upstream promoter. The
asterisk indicates the base conserved between 3 species. (C) The coexpression assay performed in the HepG2 cells using expression vectors for FLI-1
and GATA-1, and PF4-luc with or without a mutation at the 273 or 251 ETS site. (D) The transient transfection assay performed using PF4-luc with or
without a mutation at the 251 ETS site and the megakaryocytic HEL cells. * p,0.05 between the wild type and the mutant promoter. (E) Control or
FLI-1 siRNA was transfected into HEL cells. The expression levels of PF4 and FLI-1 mRNA in the transfected cells were measured by real-time RT-PCR.
All the coexpression and siRNA assays were performed 3 times. Data are represented as the mean 6 SE. * p,0.05 between Control and FLI-1 siRNA.
doi:10.1371/journal.pone.0024837.g003
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observed with the 273 ETS site (Figure 4F; Figure S3).
Consistent with the EMSA, a chromatin immunoprecipitation
(ChIP) assay using HEL cells also demonstrated the bindings of
FLI-1, ELF-1, and GABP to the 251 ETS site (Figure 4G).
Together, these findings suggest that FLI-1, ELF-1, and GABP
bind to the 251 ETS site in the PF4 promoter.
ELF-1 and GABP regulate the PF4 gene expression
through the 251 ETS site
To determine the role of ELF-1 and GABP in mediating PF4
promoter activity, coexpression assays were performed. Overex-
pression of ELF-1 or GABP (GABPa, b, and c) resulted in strong
activation of the wild-type promoter, but not the 251 ETS mutant
promoter in HepG2 cells (Figure 5A). The effect of GABP on
promoter activation was recapitulated by combined expression of
either GABPa/b or GABPa/c (Figure 5B). To determine
whether ELF-1 and/or GABP functionally interact with GATA-
1 to mediate promoter activity, co-transfection assays in HepG2
cells were performed. Unlike FLI-1, ELF-1 and GABP did not
synergistically activate the PF4 promoter with GATA-1
(Figure 5C). These results demonstrated that ELF-1 and GABP
activate the PF4 promoter through the 251 ETS site while these
factors cannot synergistically activate the promoter with GATA-1.
To investigate whether ELF-1 and/or GABP regulate the
endogenous PF4 gene expression in megakaryocytic cells, siRNA
against ELF-1 or GABP were transfected into HEL cells. ELF-1
siRNA resulted in 62% and 40% reduction in ELF-1 and PF4
mRNA expression (Figure 5D). On the other hand, GABP
siRNA resulted in 32% reduction of GABP and 66% increase of
PF4 mRNA expression (Figure 5E). These results indicated that
both ELF-1 and GABP regulates the PF4 gene expression.
Figure 4. FLI-1, ELF-1, and GABP bind to the 251 ETS site. (A) EMSA performed with the 251 ETS probe. Nuclear extracts from HEL cells were
added to lanes 2–8. Competition assays were performed with wild type (lanes 3 and 4) or 251 ETSmut (lanes 5 and 6) competitors. The supershift
assays were performed with the antibody against FLI-1 and control antibody (lanes 7 and 8). Four shifted bands were labeled I, II, IIIa and IIIb. Asterisk
indicates the specific shifted band IIIa. (B) EMSA was performed with the in vitro translated FLI-1 and control protein (Vector) (lanes 3 and 6). The
supershift assay was performed with the antibody against FLI-1 and control antibody (lanes 5 and 6). (C) The supershift assay was performed with
antibodies against ELF-1 and GABP or control antibody (lanes 3–7). GABPb/c antibody recognizes both GABPb and its splicing isoform GABPc.( D)
EMSA was performed with the in vitro translated ELF-1 and control protein (lanes 3–6). The supershift assay was performed with the antibody against
ELF-1 and control antibody (lanes 5 and 6). (E) EMSA was performed with the in vitro translated GABP (GABP a, b, and c) and control protein (lanes 3–
13). The supershift assay was performed with the antibody against GABP and control antibody. Shifted bands derived from GABPa, GABPa/b and
GABPb/c complexes are labeled a, a/b, and a/c, respectively. (F) EMSA was performed with the 251 ETSmut probe and in vitro translated FLI-1, ELF-1,
GABP, and control protein. (G) ChIP assay was performed with HEL cells by using antibodies against ETS factors or control antibody.
Immunoprecipitated DNA was measured by real-time PCR with primers to amplify the human PF4 promoter region, including the 251 ETS site, or the
GAPDH locus as a negative control region. A representative of 3 independent experiments is shown.
doi:10.1371/journal.pone.0024837.g004
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and GABP are positive regulators for the PF4 gene expression,
siRNA knockdown of GABP led to increased expression of PF4 in
HEL cells. We speculated that this controversial effect was
observed because the decrease of GABP promoted FLI-1 binding
to the 251 ETS sites. In fact, EMSA using recombinant proteins
showed competitive binding of FLI-1, ELF-1, or GABP at the 251
ETS site (Figure S4). Thus, these data suggest that FLI-1, ELF-1,
and GABP competitively bind to the 251 ETS sites and regulate
PF4 gene expression.
Expression patterns of FLI-1, ELF-1, and GABP in human
megakaryocytic differentiation
To investigate and compare the temporal expression patterns of
the ETS factors FLI-1, ELF-1, and GABP during megakaryocytic
differentiation, mRNA levels of ELF-1 and GABPa were
measured by real-time PCR (using the same cDNA prepared in
Figure 1). As shown in Figure 1, both ELF-1 and GABPa were
expressed during megakaryocytic differentiation. However, unlike
the expression pattern of FLI-1 expressions of ELF-1 and GABPa
had decreased by day 4. This finding suggests that while all 3 ETS
factors may play a role in mediating PF4 expression, they likely
function in temporally distinct ways.
The 251 ETS site is important for PF4 promoter
activation in differentiating megakaryocytes
To confirm a role for the 251 ETS site in mediating the PF4
gene expression in megakaryocytes, the wild type or the 251
ETSmut PF4 promoter was coupled to GFP. A single copy of the
resulting transgenic cassette was targeted to the Hprt locus in ES
cells by homologous recombination (Figure S5A; Figure 6A).
Two correctly targeted recombinant clones for each construct
were differentiated into megakaryocytic lineage by culturing with
OP9 stroma cells and TPO. At day 10, a number of differentiated
cells were positive for acetylcholine esterase activity (Figure 6B
upper panel), and 30% of the cells were positive for CD41 (data
not shown). In addition, proplatelets were also observed
(Figure 6B lower panel), suggesting differentiation into the
megakaryocytic lineage. Megakaryocytes and proplatelets from
cells carrying the wild type PF4 promoter had strong GFP
expression, while those from 251 ETSmut showed significantly
decreased GFP expression (Figure 6C; Figure S5B). FACS
analysis demonstrated that the mutation of the 251 ETS site
significantly decreased the number of GFP positive megakaryo-
cytic cells (Figure 6D). These observations suggest that the 251
ETS site is important for the activation of the PF4 promoter
during megakaryocytic differentiation.
Figure 5. FLI-1, ELF-1, and GABP activate the PF4 promoter through the 251 ETS site. (A) Coexpression assays were performed in HepG2
cells by using the expression vectors for FLI-1, ELF-1, and GABP (consisting of a, b and c), and luciferase constructs containing the 1.1-kb promoter
with or without a mutation in the 251ETS site. (B) Coexpression assay was performed with expression vectors for GABPa, b, and c, and luciferase
constructs containing 1.1-kb promoter with or without a mutation in the 251 ETS site. (C) Coexpression assay was performed with GATA-1
expression vector and expression vectors for FLI-1, ELF-1 and GABP. In all experiments, an empty vector (pcDNA3) was used as a control vector. All of
the coexpression assays were performed 3 times. Data are represented as the mean 6 SE. (D, E) Control siRNA, or siRNA for ELF-1 or GABPa was
transfected into HEL cells. The expression levels of PF4, and ELF-1 or GABPa mRNAs in the transfected cells were measured by real-time PCR. * p,0.05
between Control and ELF-1 or GABP siRNA.
doi:10.1371/journal.pone.0024837.g005
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Multiple ETS binding sites are often found in the megakaryo-
cyte-specific gene promoters. However, it has not been clearly
shown how multiple ETS binding sites regulate megakaryocyte-
specific genes. The rat PF4 promoter contains more than 20 ETS
core sequences in it. In this study, we identified a novel, functional
ETS binding site (251 ETS site) in the PF4 promoter. To evaluate
the physiological function of the 251 ETS site for the PF4
promoter activity in megakaryocytes, we developed and used a
novel reporter gene assay using homologously recombined mouse
ES cells (Figure 6; Figure S5). It has been difficult to analyze the
promoter activity in intact megakaryocytes because of the small
number of megakaryocytes in vivo and the technical difficulty of
Figure 6. The 251 ETS site is important for PF4 promoter activity in differentiating megakaryocytes. (A) Two ES cell lines with
transgenes containing PF4 promoter with or without a mutation in the 251 ETS site were prepared. The genomic DNA sequence between these ES
cell lines differed only at the 21 ETS site. (B) Differentiated cells from ES cells with a wild type promoter were stained for acetylcholine esterase
(upper panel). These cells included GFP positive proplatelets (lower panel). (C) GFP expression level was compared between 2 cell lines with WT and
251 ETSmut promoters. The arrowheads indicate proplatelets. (D) The ratio of GFP expressing CD41-positive cells derived from ES cell lines
containing the wild type or 251 ETSmut promoter was analyzed by a flow cytometer.
doi:10.1371/journal.pone.0024837.g006
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proplatelets. Our system enables the promoter activity in normal
differentiating megakaryocytes and proplatelets to be evaluated.
Using this system we evaluated the function of the 251 ETS site
using 2 independent ES cell lines containing a wild type or mutant
PF4 promoter coupled to the GFP gene. The insertion of a singly
copy transgene into the Hprt locus allowed to compare the
expression levels of the reporter gene between ES cell lines in the
same genomic DNA context [24]. By differentiating these ES cell
lines into megakaryocytic lineage, we succeeded in demonstrating
that the 251 ETS site is important for the activation of PF4 gene
expression in megakaryocytes and proplatelets. This reporter assay
system should be a powerful tool for analyzing physiological
promoter function in normal megakaryocytes and proplatelets.
Our data demonstrate that multiple ETS family proteins
regulate the PF4 gene expression. EMSA and coexpression assays
indicate that FLI-1, ELF-1, and GABP bind to the 251 ETS site
and activate the PF4 promoter. In addition, the ChIP assay
showed that FLI-1, ELF-1, and GABPa bind to the 251 ETS site
in vivo. ELF-1 was originally described as a regulator of T-cell
specific genes [25]. To our knowledge, this is the first study to
demonstrate a role for ELF-1 in mediating the megakaryocyte-
specific gene expression. GABP consists of 2 subunits, GABPa and
GABPb (or its splicing isoform, GABPc). GABPa contains the
ETS DNA-binding domain, while GABPb is required for nuclear
translocation and transactivation. Mammalian GABP is ubiqui-
tously expressed in all tissues and has been implicated in several
critical cellular processes such as cellular differentiation, cell cycle,
cell survival and mitochondrial respiration [23]. In addition to
regulating the expression of housekeeping genes, GABP has been
shown to regulate the expression of cell-type specific genes in
several distinct lineages, including myeloid cells, lymphocytes,
mast cells and endothelial cells [16,23]. A few reports indicate the
importance of GABP in the regulation of megakaryocyte-specific
genes (e.g., GPIIb and cMpl) [26,27]. Comparing with FLI-1, ELF-
1, and GABP, ETS-1 has a small effect on the PF4 gene expression
in the co-expression assay using HepG2 cells, although we have
previously demonstrated that ETS-1 activates the PF4 promoter
[12]. This difference may be caused by the difference in the cell
types used in the co-expression assay. ETS-1 is known to inhibit its
DNA binding via the autoinhibitory domain, and its DNA binding
is enhanced by interacting with other transcription factors, such as
CBFb [28]. We speculated that some interacting protein that is
expressed in HEL cells but not HepG2 cells is needed for the
strong promoter activation by ETS-1.
It has been reported that multiple transcription factors can bind
to the same site and regulate gene expression. Recent genome-
wide ChIP-seq analyses have also shown an overlap in the
chromatin regions commonly bound by different members of the
ETS family [29,30,31]. In some cases, a transcriptional activator
competes with a suppressor for binding to the same site. This
mechanism enables positive or negative regulation of promoter
activity through the same site. However, in our reporter gene
assays, individual overexpression of FLI-1, ELF-1, and GABP
resulted in similar levels of PF4 promoter activity. This suggests
that all these factors are transcriptional activators of the PF4
promoter. The question is: why is the PF4 promoter regulated by
multiple transcriptional activators through the same site? In the
coexpression assay, FLI-1 but not ELF-1 and GABP synergistically
activated the PF4 promoter with GATA-1 (Figure 5C). One
potential mechanism to explain this synergistic activation may be a
direct interaction between FLI-1 and GATA-1 on the GATA-1
binding site, because FLI-1 expression enhanced promoter
activation by GATA-1 without binding to the 251 ETS site
(Figure 3C; Figure S2). Alternatively, GATA-1 may enhance
the FLI-1 binding to the other ETS site, such as the 271 ETS site.
In either case, this synergistic activation by FLI-1 and GATA-1
suggests distinct roles for the ETS family proteins in mediating
gene expression by interacting with other transcription factors.
The siRNA knockdown of GABPa slightly increased the PF4 gene
expression although the overexpression of GABP itself activated
the promoter activity in the co-expression assay (Figure 5A, E).
This controversial observation also suggests the possibility that
FLI-1, ELF-1, and GABP competitively bind to the 251 ETS site,
and that the relative expression levels of these 3 factors are
important for the regulation of the PF4 gene expression. Our real-
time PCR analysis indicated that the expression of FLI-1 increased
during megakaryocytic differentiation, whereas the expression of
ELF-1 and GABP decreased at day 4 and did not drastically
change at days 6 and day 10 (Figure 1). This suggests the
possibility that FLI-1 plays a role in the late stage of
megakaryocytic differentiation, whereas ELF-1 and GABP are
necessary during the early stage. Consistent with this hypothesis,
the importance of the FLI-1 at the late stage of megakaryocytic
differentiation and gene expression was demonstrated by inducible
FLI-1 knock out and FLI-1 mutant mice [32,33]. Furthermore,
Pang et al. reported that GABP regulates megakaryocyte-specific
genes that are expressed at the early differentiation stage, while
FLI-1 regulates genes expressed at the late stage [27]. In the
regulation of the late megakaryocytic marker PF4 either GABP or
ELF-1 may bind to the 251 ETS site and moderately activate the
promoter at the early stage, whereas FLI-1 may displace them and
strongly activate the promoter with GATA-1 at the late stage. Our
EMSA data indicate the possibility that FLI-1 displaces ELF-1 and
GABP from the 251 ETS site (Figure S4). Together, these results
implicate the differentiation stage-specific regulation of PF4 gene
expression by multiple ETS factors.
Inconsistent with our result, Pang’s group demonstrated that
GABP synergistically activates the GPIIb promoter with GATA-1
under the existence of FOG-1. This suggests the possibilities that
FOG-1 is essential for synergistic activation of the PF4 promoter
by GABP and GATA-1 and that synergistic activation by GABP
and GATA-1 does not occur on the PF4 promoter. More detailed
analyses about ETS family proteins and their functionally
associated proteins will be important to understand megakaryo-
cyte-specific and differentiation stage-specific PF4 gene expression.
Supporting Information
Figure S1 Expression of transcription factors in tran-
sient transfection assay. Expression levels of the transcription
factors and GAPDH (as a control) in the transfected HepG2 cells
were analyzed by western blotting. The asterisks indicate bands
derived from FLI-1 between non-specific bands.
(TIF)
Figure S2 Activation of the PF4 promoter by FLI-1
through the 251 ETS site. Coexpression assay was performed
in HepG2 cells by using FLI-1 and GATA-1 expression vectors and
PF4-luc with or without a mutation in the 273 or 251 ETS site.
(TIF)
Figure S3 Binding of FLI-1, ELF-1, or GABP to the 273
ETS site. EMSA was performed with the 273 ETS or 251 ETS
probe, and FLI-1, ELF-1, and GABP prepared by in vitro
translation. The arrows indicate the shifted bands derived from
FLI-1 (F), ELF-1 (E) and GABP (G). The DNA sequences of
oligonucleotides for the 273 ETS probe are shown in Table S1.
(TIF)
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PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e24837Figure S4 Competitive binding of FLI-1, and ELF-1 or
GABP to the 251 ETS site. (A) EMSA was performed with the
251 ETS probe, and in the protein mixture containing ELF-1 and
various amounts of FLI-1. The arrows indicate the shifted bands
derived from ELF-1 (E) and FLI-1 (F). (B) EMSA was performed
with the 251 ETS probe, and the protein mixture containing
GABPa and various amounts of FLI-1. The arrows indicate the
shifted bands derived from GABPa (G) and FLI-1 (F).
(TIF)
Figure S5 Promoter activity of the wild type or mutant
PF4 promoter during megakaryocytic differentiation. (A)
The transgene was inserted into the Hprt locus by homologous
recombination. (B) Two ES cell lines with transgenes containing the
PF4 promoter with or without a mutation in the 251 ETS site were
differentiated into megakaryocytic lineage. The GFP expression
level was compared between the 2 cell lines from days 6 to 12.
(TIF)
Table S1 Sequences of the oligonucleotides.
(XLS)
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